JPH0222221A - Capsule having improved lubricating property and disintegrating property - Google Patents
Capsule having improved lubricating property and disintegrating propertyInfo
- Publication number
- JPH0222221A JPH0222221A JP17205688A JP17205688A JPH0222221A JP H0222221 A JPH0222221 A JP H0222221A JP 17205688 A JP17205688 A JP 17205688A JP 17205688 A JP17205688 A JP 17205688A JP H0222221 A JPH0222221 A JP H0222221A
- Authority
- JP
- Japan
- Prior art keywords
- calcium
- capsule
- gelatin
- capsules
- calcium salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 62
- 230000001050 lubricating effect Effects 0.000 title abstract 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 25
- 108010010803 Gelatin Proteins 0.000 claims abstract description 23
- 239000008273 gelatin Substances 0.000 claims abstract description 23
- 229920000159 gelatin Polymers 0.000 claims abstract description 23
- 235000019322 gelatine Nutrition 0.000 claims abstract description 23
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 23
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000011575 calcium Substances 0.000 claims abstract description 19
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 19
- 159000000007 calcium salts Chemical class 0.000 claims abstract description 15
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 12
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 12
- 210000003278 egg shell Anatomy 0.000 claims abstract description 7
- 235000015278 beef Nutrition 0.000 claims description 3
- 229940036811 bone meal Drugs 0.000 claims description 3
- 239000002374 bone meal Substances 0.000 claims description 3
- 239000002075 main ingredient Substances 0.000 claims description 2
- 229960005069 calcium Drugs 0.000 abstract description 17
- 238000002156 mixing Methods 0.000 abstract description 9
- 102000002322 Egg Proteins Human genes 0.000 abstract description 5
- 108010000912 Egg Proteins Proteins 0.000 abstract description 5
- 239000007901 soft capsule Substances 0.000 abstract description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract description 4
- 235000010216 calcium carbonate Nutrition 0.000 abstract description 3
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 abstract description 3
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 abstract description 3
- 239000001527 calcium lactate Substances 0.000 abstract description 3
- 229960002401 calcium lactate Drugs 0.000 abstract description 3
- 235000011086 calcium lactate Nutrition 0.000 abstract description 3
- 235000019700 dicalcium phosphate Nutrition 0.000 abstract description 3
- 210000002784 stomach Anatomy 0.000 abstract description 3
- 230000002378 acidificating effect Effects 0.000 abstract description 2
- 239000001569 carbon dioxide Substances 0.000 abstract description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 abstract description 2
- 239000000843 powder Substances 0.000 abstract description 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 239000004227 calcium gluconate Substances 0.000 abstract 1
- 229960004494 calcium gluconate Drugs 0.000 abstract 1
- 235000013927 calcium gluconate Nutrition 0.000 abstract 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 abstract 1
- 230000003405 preventing effect Effects 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 239000011521 glass Substances 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 5
- 230000001186 cumulative effect Effects 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 235000001465 calcium Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000007902 hard capsule Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 101001010152 Aplysia californica Probable glutathione transferase Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は主としてその滑走性及び崩壊性を向上せしめた
カプセル皮膜を有するカプセルに関するものである。
本発明に於いてカプセルとはゼラチン、グリセリン、水
等を主成分とするカプセル皮膜により形成した一種の密
閉容器を意味し、カプセル剤とは前記カプセル内に医薬
品、食品又は化粧品等の内容物を充填した固形剤を意味
するものである。DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention primarily relates to a capsule having a capsule coating that improves its sliding properties and disintegration properties.
In the present invention, a capsule refers to a type of airtight container formed by a capsule film containing gelatin, glycerin, water, etc. as the main ingredients, and a capsule is a container in which the contents such as pharmaceuticals, foods, or cosmetics are placed inside the capsule. It means a filled solid agent.
(従来の技術)
一般に、カプセル剤として良好な品質を有するためには
、カプセル皮膜が一定の含水率を維持していることが必
要である。(Prior Art) Generally, in order to have good quality as a capsule, it is necessary for the capsule film to maintain a constant water content.
然しながら、実際にはカプセル剤の内、特に軟カプセル
剤の含水率は環境条件によって大きく変化し易く、殊に
、高湿度、高温度条件の下ではカプセル皮膜は湿潤軟化
しカプセル自体の滑走性が悪くなるためカプセル剤の包
装乃至充填作業が円滑に行い難い欠点がある。However, in reality, the moisture content of capsules, especially soft capsules, tends to vary greatly depending on environmental conditions. In particular, under conditions of high humidity and temperature, the capsule film becomes wet and softens, and the slipperiness of the capsule itself is affected. This has the disadvantage that it is difficult to carry out packaging and filling of capsules smoothly.
又、カプセル剤同志が互いに粘着接合して服用時にはが
せなかったり、軟化変形して外観上、商品価値を失って
しまう等の欠点があった。In addition, the capsules have other drawbacks, such as being adhesively bonded to each other and not being able to be removed when ingested, or softening and deforming, resulting in a loss of commercial value in terms of appearance.
更に、カプセル剤は腸溶性カプセル剤等の一部の例外を
除いて胃内で速やかに崩壊し、内容物を放出することが
望まれる。Furthermore, with some exceptions such as enteric-coated capsules, capsules are desired to disintegrate quickly in the stomach and release the contents.
然るに、カプセル皮膜の基材であるゼラチンは長期保存
中に種々の経時変化を来たしその崩壊性の低下をもたら
すこともある。However, gelatin, which is the base material of the capsule film, undergoes various changes over time during long-term storage, which may lead to a decrease in its disintegrability.
そのために、従来ではゼリー強度及び粘度が一定値以下
のゼラチンを原料としたり、あるいはゼラチンがタンパ
ク質であることを利用9してゼラチンにタンパク分解酵
素或いは崩壊助剤として、特定のアミノ酸を配合したり
してカプセル剤の崩壊性を促進させる方法が提案されて
いるが、必ずしも満足するものは得られなかった。To this end, conventional methods have been to use gelatin as a raw material whose jelly strength and viscosity are below a certain value, or to take advantage of the fact that gelatin is a protein9, to mix specific amino acids into gelatin as proteolytic enzymes or disintegration aids. Although methods have been proposed for promoting the disintegration properties of capsules, they have not always been satisfactory.
又、公知技術として特開昭61−15831号公報を挙
げることができるが、これは炭酸水素ナトリウムをゼラ
チンに配合し崩壊性を改良するものであるが、製造時の
温度条件を406C以下に保持する必要があるという欠
点があった。Additionally, as a known technique, Japanese Patent Application Laid-Open No. 15831/1983 can be mentioned, which improves the disintegration property by blending sodium hydrogen carbonate into gelatin, but the temperature condition during production is maintained at 406C or less. The drawback was that it needed to be done.
(技術的課題)
而して、本発明は従来技術の欠点に鑑みなされたもので
、カプセル皮膜の滑走性及び崩壊性を向上促進するカプ
セルを提案することを技術的課題とするものである。(Technical Problem) The present invention was made in view of the shortcomings of the prior art, and its technical problem is to propose a capsule that improves and promotes the sliding properties and disintegration properties of the capsule film.
(技術的手段)
本発明では上記の技術的課題を解決するために、下記の
如く構成しである。(Technical Means) In order to solve the above technical problem, the present invention is configured as follows.
第一に、
炭酸カルシウム、リン酸水素カルシウム、乳酸カルシウ
ム、又はグリコン酸カルシウム等のカルシウム塩又は該
カルシウム塩を主成分とする卵殻、牛骨粉、貝殻等の天
然カルシウム剤をゼラチンに対し約10重量%以上の割
合で配合しカプセルの滑走性を高くしである。First, about 10% of gelatin is mixed with a calcium salt such as calcium carbonate, calcium hydrogen phosphate, calcium lactate, or calcium glyconate, or a natural calcium agent such as eggshell, beef bone meal, or seashell containing said calcium salt as a main component. % or more to increase the slipperiness of the capsule.
好ましくは配合比40〜60重量%である。Preferably, the blending ratio is 40 to 60% by weight.
第二に、
前記したカルシウム塩のうち、炭酸塩又は該炭酸カルシ
ウム塩を主成分として天然炭酸カルシウム剤をゼラチン
に対し約10重量%以上の割合で配合しカプセルの滑走
性と崩壊性を高くしである。Second, among the above-mentioned calcium salts, a carbonate or a natural calcium carbonate agent containing the calcium carbonate as the main component is blended at a ratio of about 10% by weight or more to gelatin to increase the slipperiness and disintegration of the capsule. It is.
好ましくは配合比40〜60重量%である。Preferably, the blending ratio is 40 to 60% by weight.
尚、ゼラチンに対するグリセリンの添加量を大にすれば
軟カプセルになり、添加量を小にすれば硬カプセルにな
ることは周知のことである。It is well known that if the amount of glycerin added to gelatin is increased, soft capsules will be obtained, and if the amount added is small, hard capsules will be obtained.
第1図に於いて、lはカプセル本体でゼラチン、グリセ
リン、水等を主成分とするカプセル皮膜2により種々の
形状例えばオーバル型に形成した一種の密閉容器である
。 実際にはカプセル本体1のみが独立して存在するも
のではなく、内容物が充填されたカプセル剤が存在する
ものである。In FIG. 1, reference numeral 1 denotes a capsule body, which is a type of sealed container formed into various shapes, for example, an oval shape, by a capsule film 2 whose main components are gelatin, glycerin, water, etc. In reality, the capsule body 1 does not exist independently, but a capsule filled with the contents exists.
3は炭酸カルシウム、リン酸水素カルシウム、乳酸カル
シウム、グリコン酸カルシウム等のカルシウム塩で前記
カプセル皮WIz内に適宜量配合しである。3 is a calcium salt such as calcium carbonate, calcium hydrogen phosphate, calcium lactate, calcium glyconate, etc., which is blended in an appropriate amount in the capsule skin WIz.
換言すれば、ゼラチンに対し約10重量%以上の割合で
配合しである。In other words, it is blended in a proportion of about 10% by weight or more based on gelatin.
好ましくは配合比40〜60重量%である。Preferably, the blending ratio is 40 to 60% by weight.
4は卵殻、牛骨粉、貝殻等の天然カルシウム剤で前記し
たカルシウム塩3を主成分としてこれに該天然カルシウ
ム塩を混ぜたものをカプセル皮膜2内に適宜量配合しで
ある。4 is a natural calcium agent such as eggshell, beef bone meal, seashell, etc. The calcium salt 3 mentioned above is the main component, and a mixture of the natural calcium salt is blended into the capsule film 2 in an appropriate amount.
換言すればゼラチンに対し約10重量%以上の割合で配
合しである。In other words, it is blended in a proportion of about 10% by weight or more based on gelatin.
好ましくは配合比40〜60重量%である。Preferably, the blending ratio is 40 to 60% by weight.
5は内容物で医薬品、健康食品等であり、粉末状、果粒
状、液状、泥状等である。The contents 5 are medicines, health foods, etc., and are in the form of powder, fruit, liquid, slurry, etc.
6はカプセル剤でゼラチンを基剤として造ったカプセル
本体1内に内容物5を充填した固形剤である。6 is a capsule, which is a solid preparation in which the contents 5 are filled into a capsule body 1 made of gelatin as a base.
(効 果)
(a)請求項1に記載の発明に於いて、カルシウム塩、
天然カルシウム剤の添加により付着防止効果が顕著とな
り滑走性が良好となった。(Effect) (a) In the invention described in claim 1, calcium salt,
Addition of a natural calcium agent resulted in a significant anti-adhesion effect and improved sliding properties.
又、カプセル皮膜の膜厚が厚くなり空気酸化の影響が少
なくなった。In addition, the thickness of the capsule film became thicker, and the influence of air oxidation was reduced.
更に、天然カルシウム剤の場合は使用量には法的規制が
ないことよりして安全なカルシウムである。Furthermore, in the case of natural calcium preparations, there are no legal restrictions on the amount used, so calcium is safe.
(b)請求項2に記載の発明に於いて、カプセルは、炭
酸カルシウムが胃中の酸性条件下で炭酸ガスを発生し、
ゼラチン軟カプセルが迅速且つ確実に崩壊される。(b) In the invention set forth in claim 2, the capsule contains calcium carbonate that generates carbon dioxide gas under acidic conditions in the stomach;
Soft gelatin capsules are quickly and reliably disintegrated.
(実施例1)
(1)カプセル皮膜の配合比
カプセル皮膜を形成するゼラチン、濃グリセリン、各種
カルシウムを検体N00l N10の如く第1表の割合
にて調合し試料とした。(Example 1) (1) Compounding ratio of capsule film Gelatin, concentrated glycerin, and various types of calcium forming the capsule film were mixed in the proportions shown in Table 1, such as specimens N00l and N10, and used as samples.
尚、卵殻カルシウム剤は炭酸カルシウムが主成分である
。Note that the eggshell calcium agent has calcium carbonate as its main component.
第 1 表 により混合した。Part 1 table Mixed by
このようにして得られたゼラチン溶液を軟カプセル製造
装置(図示せず)に仕込み、内容物5を充填し、常法に
てオーバル5型のカプセル剤6を成形した。The gelatin solution thus obtained was placed in a soft capsule manufacturing apparatus (not shown), filled with contents 5, and oval 5-shaped capsules 6 were molded in a conventional manner.
尚、前記した内容物5としての充填液は、流動、<ラフ
インを使用し、充填量を250mg、乾燥前の皮(2)
カプセル剤の製造方法について。In addition, the filling liquid as the above-mentioned content 5 is a fluid, < rough-in is used, the filling amount is 250 mg, and the skin (2) before drying is used.
About the manufacturing method of capsules.
第1表に示した配合比にて調合したゼラチンと濃グリセ
リンを温度60’cにて混合攪拌し完全に溶解した後、
その中に各種類のカルシウムを所定の配合比(3)付着
テスト方法とその結果
条件(a)
オーバル5型のカプセル剤6を乾燥検体として用い、6
検i 〜t oを各10個5つ取り上げて6号ガラスサ
ンプルビン7内に不規則に入れ、ビン口を開口した状態
にて温度30’″C2相対湿度(RH)100%の恒温
恒湿槽内に24時間保存し、その後、6′♀ガラスサン
プルビン7を取り出し、室温に戻してから以下のテスト
を行った場合。After mixing and stirring gelatin and concentrated glycerin prepared at the mixing ratio shown in Table 1 at a temperature of 60'C until completely dissolved,
(3) Adhesion test method and result conditions (a) Oval 5 type capsule 6 was used as a dry sample, 6
Take 5 samples of 10 samples from each sample, place them randomly in a No. 6 glass sample bottle 7, and keep the bottle mouth open at a constant temperature and humidity of 30'C2 relative humidity (RH) 100%. When stored in the tank for 24 hours, the 6'♀ glass sample bottle 7 was taken out, returned to room temperature, and then the following test was performed.
条件(b)
前記条件(a)に於いて、温度40″′C2相対湿度(
RH)60%に変更した場合。Condition (b) In the above condition (a), the temperature is 40'''C2 relative humidity (
RH) when changed to 60%.
以下に条件(a)1条件(b)の2つ番こつき夫々テス
ト1.テスト2の2種類を行った。Below are test 1 for condition (a) and condition (b). Two types of test 2 were conducted.
(テスト1)
第2図乃至第3図に示す如くカプセル剤6カζ不規貝1
jに入っているガラスサンプルビン7を机8上に倒した
。(Test 1) As shown in Figures 2 and 3, 6 capsules and 1
I knocked down the glass sample bottle 7 contained in j on the desk 8.
その時のガラスサンプルビン7の内壁から落下したカプ
セル剤6の数値(累積数値)を第2表に示した。Table 2 shows the numerical values (cumulative numerical values) of the capsules 6 that fell from the inner wall of the glass sample bottle 7 at that time.
(テスト2)
第4図に示す如くガラスサンプルビン7を机8より高さ
h= L cm、3cm、5cmにて落下せしめた。(Test 2) As shown in FIG. 4, the glass sample bottle 7 was dropped from the desk 8 at heights h=L cm, 3 cm, and 5 cm.
その時のガラスサンプルビン7の内壁から落下したカプ
セル剤6の数値(累積数値)も第2表中に示した。The numerical values (cumulative numerical values) of the capsules 6 that fell from the inner wall of the glass sample bottle 7 at that time are also shown in Table 2.
第 2 表 条件30”c、RH100%本数値
は累積の数を示す。Table 2 Condition 30''c, RH 100% This value indicates the cumulative number.
条件(b)即ち温度40’c、相対湿度60%の下で保
存したカプセル剤6はガラスサンプルビン7を机8上に
倒したのみで10個全部、内壁より落下した。All 10 capsules 6 stored under condition (b), that is, a temperature of 40'C and a relative humidity of 60%, fell from the inner wall when the glass sample bottle 7 was only knocked down on the desk 8.
(4)付着テスト結果に甚く考察
カプセル皮膜2内にカルシウムが入っているカプセル剤
はカルシウムが入っていないカプセル剤に比し付着性が
低く、滑走性が大であることが判明した。(4) Detailed consideration of the adhesion test results It was found that capsules containing calcium in the capsule film 2 had lower adhesion and greater sliding properties than capsules containing no calcium.
(5)崩壊テスト方法とその結果
日本薬局法の崩壊試験法(公知)に基き温度37@Cの
人工胃液中にて崩壊テストを行った。(5) Disintegration test method and results A disintegration test was conducted in artificial gastric fluid at a temperature of 37@C based on the disintegration test method (known) of the Japanese Pharmacopoeia Law.
その結果を第3表に示す。The results are shown in Table 3.
尚、n=6の意味は同一種類のカプセル剤を6個採用し
夫々1回イつ延ベロ回のテストを行ったことである。Incidentally, n=6 means that six capsules of the same type were used and each was subjected to one round test.
第 3 表 n=6である。Table 3: n=6.
壊時間で約4分程遠かった。It was about 4 minutes away in terms of destruction time.
(6)崩壊テスト結果に甚く考察
カプセル皮膜2内に炭酸カルシウムが入っているカプセ
ル剤は炭醜カルシウムが入っていないカプセル剤に比べ
、崩壊性が速いことが判明した。(6) Consideration of disintegration test results It was found that capsules containing calcium carbonate in the capsule film 2 had faster disintegration than capsules containing no calcium carbonate.
(7)カプセル皮膜の厚さ測定方法とその結果カプセル
剤の乾燥後、検体のカプセル中心部を切断し、Il微鏡
にて断面の厚さを測定した。(7) Method and results for measuring the thickness of the capsule film After the capsule was dried, the center of the capsule of the specimen was cut, and the thickness of the cross section was measured using an Il microscope.
その結果を第4表に示す。The results are shown in Table 4.
第 4 表 n=5
ルシウム剤が入っており、検鍔0は無カルシウム面して
、皮膜厚さの測定結果によると、カルシウム入りの方が
約0.08mm皮膜が厚かった。Table 4: n=5 A lucium agent was included, and test tsuba 0 had a calcium-free surface, but according to the measurement results of the film thickness, the film with calcium was approximately 0.08 mm thicker.
(8)皮膜厚さ測定結果に基く考察
カプセル皮膜2内にカルシウムが入っているカプセル剤
の皮膜厚さはカルシウムが入っていないものに比べ膜厚
が厚いことが判明した。(8) Discussion based on the results of film thickness measurement It was found that the film thickness of capsules containing calcium in the capsule film 2 was thicker than that of capsules containing no calcium.
従って、空中酸化の影響少なく経時的保存性が大である
。Therefore, it is less affected by air oxidation and has excellent storage stability over time.
(実施例2)
ゼラチンに対し20重量%の配合比で卵殻カルシウム剤
を加えたゼラチン水溶液を用い、浸漬法にて硬カプセル
剤を成形した。(Example 2) Hard capsules were molded by a dipping method using an aqueous gelatin solution to which an eggshell calcium agent was added at a blending ratio of 20% by weight to gelatin.
このカプセル剤を前記実施例1で得た軟カプセル剤と同
様のテストを行った結果、滑走性、崩壊性の向上、膜厚
の増加が認められた。(データの添附を省略)This capsule was subjected to the same tests as the soft capsule obtained in Example 1, and as a result, improvements in slipping properties, disintegration properties, and increase in film thickness were observed. (Data attachment omitted)
第1図は本発明品の要部の拡大斜視図、第2図乃至第4
図は本発明品の付着性のテストを行っている状態の正面
図である。
1・・・カプセル本体 2・Φeカプセル皮膜6・・・
カプセル剤Figure 1 is an enlarged perspective view of the main parts of the product of the present invention, Figures 2 to 4
The figure is a front view of the product of the present invention being tested for adhesion. 1... Capsule body 2. Φe capsule membrane 6...
capsules
Claims (2)
、卵殻、牛骨粉、貝殻等の天然カルシウム剤を、ゼラチ
ンに対し約10重量%以上の割合で配合した滑走性を改
良したカプセル(1) Capsules with improved gliding properties that contain calcium salts or natural calcium agents containing calcium salts as the main ingredient, such as eggshells, beef bone meal, shells, etc., at a ratio of about 10% by weight or more to gelatin.
カルシウム塩を主成分とする卵殻、貝殻等の天然カルシ
ウム剤を、ゼラチンに対し約10重量%以上の割合で配
合した滑走性及び崩壊性を改良したカプセル(2) Calcium carbonate among calcium salts or natural calcium agents such as eggshells and seashells containing calcium carbonate as a main component are blended at a ratio of about 10% by weight or more to gelatin to improve sliding and disintegration properties. improved capsule
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63172056A JP2572266B2 (en) | 1988-07-11 | 1988-07-11 | Capsules with improved gliding and disintegration properties |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63172056A JP2572266B2 (en) | 1988-07-11 | 1988-07-11 | Capsules with improved gliding and disintegration properties |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0222221A true JPH0222221A (en) | 1990-01-25 |
| JP2572266B2 JP2572266B2 (en) | 1997-01-16 |
Family
ID=15934716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63172056A Expired - Lifetime JP2572266B2 (en) | 1988-07-11 | 1988-07-11 | Capsules with improved gliding and disintegration properties |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2572266B2 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05222990A (en) * | 1992-02-12 | 1993-08-31 | Mitsubishi Motors Corp | Engine idle control device with intake / exhaust valve stop mechanism |
| US6333047B1 (en) | 1997-05-09 | 2001-12-25 | Daiichi Kasei Co., Ltd. | Molded capsule superior in strength and stability and method for preparing same |
| US7867513B2 (en) | 2004-02-17 | 2011-01-11 | Eisai R&D Management Co., Ltd. | Soft capsule |
| US7891335B2 (en) | 2008-06-06 | 2011-02-22 | Honda Motor Co., Ltd. | Control system for internal combustion engine |
| US20110206763A1 (en) * | 2010-02-22 | 2011-08-25 | Gelita | Rapid-release encapsulation composition |
| JP2022551155A (en) * | 2019-10-10 | 2022-12-07 | キャプシュゲル・ベルジウム・エヌ・ヴィ | Gelatin capsule with ground calcium carbonate |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61115019A (en) * | 1984-11-09 | 1986-06-02 | Nippi Zerachin Kogyo Kk | Gelatin capsule coating film |
-
1988
- 1988-07-11 JP JP63172056A patent/JP2572266B2/en not_active Expired - Lifetime
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61115019A (en) * | 1984-11-09 | 1986-06-02 | Nippi Zerachin Kogyo Kk | Gelatin capsule coating film |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05222990A (en) * | 1992-02-12 | 1993-08-31 | Mitsubishi Motors Corp | Engine idle control device with intake / exhaust valve stop mechanism |
| US6333047B1 (en) | 1997-05-09 | 2001-12-25 | Daiichi Kasei Co., Ltd. | Molded capsule superior in strength and stability and method for preparing same |
| US7867513B2 (en) | 2004-02-17 | 2011-01-11 | Eisai R&D Management Co., Ltd. | Soft capsule |
| US7891335B2 (en) | 2008-06-06 | 2011-02-22 | Honda Motor Co., Ltd. | Control system for internal combustion engine |
| US20110206763A1 (en) * | 2010-02-22 | 2011-08-25 | Gelita | Rapid-release encapsulation composition |
| JP2022551155A (en) * | 2019-10-10 | 2022-12-07 | キャプシュゲル・ベルジウム・エヌ・ヴィ | Gelatin capsule with ground calcium carbonate |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2572266B2 (en) | 1997-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0791037B1 (en) | Process for stabilizing gelatin products | |
| EP1042405B1 (en) | Gelatine compositions | |
| US20050031853A1 (en) | Pullulan film compositions | |
| MXPA97001839A (en) | Process to establish gelat products | |
| JP2013505928A (en) | Acid-resistant capsule | |
| WO2005105051A1 (en) | Improved pullulan capsules | |
| US5419916A (en) | Gelatin coating composition and hard gelatin capsule | |
| GB2290965A (en) | Multiple layer capsules for drugs | |
| EP0946637A1 (en) | Polymer film compositions for capsules | |
| KR102918700B1 (en) | Shell composition comprising hpmcp for enteric soft capsule and enteric soft capsule comprising the same | |
| JPH0222221A (en) | Capsule having improved lubricating property and disintegrating property | |
| CN109843271A (en) | Low cross-linking gelatin | |
| JP5766205B2 (en) | Gelatin capsule and gelatin composition for forming capsule film | |
| KR100483072B1 (en) | Film-forming composition suitable for hard capsules and method for preparing the same | |
| AU739571B2 (en) | Capsule | |
| WO2004012701A2 (en) | NOVEL pH DEPENDENT ROBUST ENTERIC POLYMERIC CONTAINER, AN IMPROVEMENT OVER EXISTING ENTERIC DOSAGE FORMS. | |
| JP3253948B2 (en) | Capsule | |
| US3239420A (en) | Gelatin composition | |
| Nagata | Cellulosecapsules–Analternative To Gelatin | |
| JP3493563B2 (en) | Capsule | |
| CA2199155C (en) | Process for stabilizing gelatin products | |
| JP2524497B2 (en) | Persistent solid agent | |
| JPH0347247B2 (en) | ||
| KR20060012008A (en) | Hard Gelatin Capsules Containing Titanium Oxide With Controlled Particle Size and Methods for Making the Same | |
| JPH1149667A (en) | Hard gelatin capsule |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081024 Year of fee payment: 12 |